Theabrownin attenuates OVA-induced allergic rhinitis by restoring lipid metabolism homeostasis and suppressing PPAR signaling pathway
Food Bioscience · 2026-11 · 85 · 110084
DOI: 10.1016/j.fbio.2026.110084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food Bioscience, 2026-11. Verfasst von Xinzhou Yan und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Suzhou Municipal Health Commission, Science and Technology Program of Suzhou.
Abstract (Originalsprache)
Introduction
Allergic rhinitis is a common type 2 immune-mediated inflammatory disease, with lipid metabolism disorder being one of its pathological features. Theabrownin, a bioactive component derived from tea, possesses anti-inflammatory and metabolic regulatory properties; however, its role in allergic rhinitis and the underlying mechanisms remain unclear.
Methods
The therapeutic potential of theabrownin against allergic rhinitis was evaluated using a murine model of OVA-induced AR. Nasal symptoms and pathological changes were assessed. Multiplex cytokine assay and untargeted serum metabolomics were performed to quantify inflammatory cytokines and lipid metabolites. In vitro, THP-1 macrophages were stimulated with OVA to induce M2 polarization, followed by theabrownin treatment. Transcriptome sequencing, WB, IF, and qRT-PCR were applied to investigate molecular mechanisms.
Results
Theabrownin significantly alleviated nasal symptoms and pathological changes in AR mice, downregulated serum levels of TNF-α, IL-13, IL-10, IL-5, and MCP-1. Untargeted metabolomics revealed that theabrownin ameliorated glycerophospholipid and cholesterol metabolism disorders. In vitro, theabrownin reversed OVA-induced M2 polarization of THP-1 cells, reducing the expression of M2 marker molecules (CD209, ALOX15, and PPARγ). KEGG enrichment analysis identified the PPAR signaling pathway as a potential key mediator, and subsequent WB, IF, and qRT-PCR confirmed that theabrownin suppressed activation of this pathway.
Conclusions
Theabrownin alleviates OVA-induced AR in mice by exerting anti-inflammatory effects and correcting lipid metabolism disorders, likely through modulation of the PPAR pathway. Our findings suggest that theabrownin is a promising immunometabolic regulator for AR treatment.
Förderung
- Suzhou Municipal Health Commission
- Science and Technology Program of Suzhou
Zitieren
APA
Yan, X., Lin, Z., Lu, L., & He, Y. (2026). Theabrownin attenuates OVA-induced allergic rhinitis by restoring lipid metabolism homeostasis and suppressing PPAR signaling pathway. Food Bioscience, 85, 110084. https://doi.org/10.1016/j.fbio.2026.110084
Vancouver
Yan X, Lin Z, Lu L, He Y. Theabrownin attenuates OVA-induced allergic rhinitis by restoring lipid metabolism homeostasis and suppressing PPAR signaling pathway. Food Bioscience. 2026;85:110084. doi:10.1016/j.fbio.2026.110084
BibTeX
@article{Yan2026,
author = {Yan, Xinzhou and Lin, Zhiqiang and Lu, Lianjun and He, Yan},
title = {Theabrownin attenuates OVA-induced allergic rhinitis by restoring lipid metabolism homeostasis and suppressing PPAR signaling pathway},
journal = {Food Bioscience},
year = {2026},
volume = {85},
pages = {110084},
doi = {10.1016/j.fbio.2026.110084}
}
EUVIMED